Search for adenosine A2A spare receptors on peripheral human lymphocytes

FEBS Open Bio

Volumn 3, Issue , 2013, Pages 1-5

  Jacquin, Laurent ^a   Franceschi, Frédéric ^a   By, Youlet ^a   Durand Gorde, Josée Martine ^a   Condo, Jocelyne ^a   Deharo, Jean Claude ^a   Michelet, Pierre ^a   Fenouillet, Emmanuel ^a   Guieu, Régis ^a   Ruf, Jean ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Adenosine A2A receptor; Agonist; Lymphocyte; MAb; Spare receptor

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR; CYCLIC AMP; MONOCLONAL ANTIBODY; RECEPTOR RESERVE;

ADULT; AGED; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DISSOCIATION CONSTANT; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; SIGNAL TRANSDUCTION;

EID: 84869788383     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2012.11.004     Document Type: Article

References (47)

1. Olah ME, Stiles GL Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 1995, 35:581-606.
2. Cohen MV, Yang XM, Downey JM Acidosis, oxygen, and interference with mitochondrial permeability transition pore formation in the early minutes of reperfusion are critical to postconditioning's success. Basic Res. Cardiol. 2008, 103:464-471.
3. Zheng J, Wang R, Zambraski E, Wu D, Jacobson KA, Liang BT Protective roles of adenosine A1, A2A, and A3 receptors in skeletal muscle ischemia and reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H3685-H3691.
4. Bjorklund O, Shang M, Tonazzini I, Dare E, Fredholm BB Adenosine A1 and A3 receptors protect astrocytes from hypoxic damage. Eur. J. Pharmacol. 2008, 596:6-13.
5. Fredholm BB, Chen JF, Masino SA, Vaugeois JM Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs. Annu. Rev. Pharmacol. Toxicol. 2005, 45:385-412.
6. Chen GJ, Harvey BK, Shen H, Chou J, Victor A, Wang Y Activation of adenosine A3 receptors reduces ischemic brain injury in rodents. J. Neurosci. Res. 2006, 84:1848-1855.
7. Hasko G, Linden J, Cronstein B, Pacher P Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug Discov. 2008, 7:759-770.
8. Bours MJ, Swennen EL, Di VF, Cronstein BN, Dagnelie PC Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 2006, 112:358-404.
9. Marone G, Vigorita S, Triggiani M, Condorelli M Adenosine receptors on human lymphocytes. Adv. Exp. Med. Biol. 1986, 195 Pt B:7-14.
10. Marone G, Petracca R, Vigorita S, Genovese A, Casolaro V Adenosine receptors on human leukocytes. IV. Characterization of an A1/Ri receptor. Int. J. Clin. Lab Res. 1992, 22:235-242.
11. Priebe T, Kandil O, Nakic M, Pan BF, Nelson JA Selective modulation of antibody response and natural killer cell activity by purine nucleoside analogues. Cancer Res. 1988, 48:4799-4803.
12. Priebe T, Platsoucas CD, Nelson JA Adenosine receptors and modulation of natural killer cell activity by purine nucleosides. Cancer Res. 1990, 50:4328-4331.
13. Priebe T, Platsoucas CD, Seki H, Fox FE, Nelson JA Purine nucleoside modulation of functions of human lymphocytes. Cell Immunol. 1990, 129:321-328.
14. Priebe T, Ruiz L, Nelson JA Role of natural killer cells in the modulation of primary antibody production by purine nucleosides and their analogs. Cell Immunol. 1990, 130:513-519.
15. Apasov SG, Sitkovsky MV The extracellular versus intracellular mechanisms of inhibition of TCR-triggered activation in thymocytes by adenosine under conditions of inhibited adenosine deaminase. Int. Immunol. 1999, 11:179-189.
16. Gessi S, Varani K, Merighi S, Cattabriga E, Pancaldi C, Szabadkai Y, Rizzuto R, Klotz KN, Leung E, Mac LS, Baraldi PG, Borea PA Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [3H]MRE 2029-F20. Mol. Pharmacol. 2005, 67:2137-2147.
17. Gessi S, Varani K, Merighi S, Cattabriga E, Avitabile A, Gavioli R, Fortini C, Leung E, Mac LS, Borea PA Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation. Mol. Pharmacol. 2004, 65:711-719.
18. Huang S, Apasov S, Koshiba M, Sitkovsky M Role of A2A extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 1997, 90:1600-1610.
19. Hoskin DW, Mader JS, Furlong SJ, Conrad DM, Blay J Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review). Int. J. Oncol. 2008, 32:527-535.
20. Koshiba M, Rosin DL, Hayashi N, Linden J, Sitkovsky MV Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. Mol. Pharmacol. 1999, 55:614-624.
21. Mirabet M, Herrera C, Cordero OJ, Mallol J, Lluis C, Franco R Expression of A2B adenosine receptors in human lymphocytes: their role in T cell activation. J. Cell Sci. 1999, 112 (Pt 4):491-502.
22. Apasov S, Koshiba M, Redegeld F, Sitkovsky MV Role of extracellular ATP and P1 and P2 classes of purinergic receptors in T-cell development and cytotoxic T lymphocyte effector functions. Immunol. Rev. 1995, 146:5-19.
23. Apasov S, Chen JF, Smith P, Sitkovsky M A(2A) receptor dependent and A(2A) receptor independent effects of extracellular adenosine on murine thymocytes in conditions of adenosine deaminase deficiency. Blood 2000, 95:3859-3867.
24. Erdmann AA, Gao ZG, Jung U, Foley J, Borenstein T, Jacobson KA, Fowler DH Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo. Blood 2005, 105:4707-4714.
25. Lappas CM, Rieger JM, Linden J A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. J. Immunol. 2005, 174:1073-1080.
26. Yang Z, Day YJ, Toufektsian MC, Xu Y, Ramos SI, Marshall MA, French BA, Linden J Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes. Circulation 2006, 114:2056-2064.
27. Csoka B, Himer L, Selmeczy Z, Vizi ES, Pacher P, Ledent C, Deitch EA, Spolarics Z, Németh ZH, Hasko G Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function. FASEB J. 2008, 22:3491-3499.
28. Himer L, Csoka B, Selmeczy Z, Koscso B, Pocza T, Pacher P, Németh ZH, Deitch EA, Vizi ES, Cronstein BH, Hasko G Adenosine A2A receptor activation protects CD4+ T lymphocytes against activation-induced cell death. FASEB J. 2010, 24:2631-2640.
29. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, Robson SC Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 2007, 204:1257-1265.
30. Sitkovsky MV T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response. Trends Immunol. 2009, 30:102-108.
31. Stephenson RP A modification of receptor theory. Br. J. Pharmacol. Chemother. 1956, 11:379-393.
32. McNeil LK, Evavold BD Dissociation of peripheral T cell responses from thymocyte negative selection by weak agonists supports a spare receptor model of T cell activation. Proc. Natl. Acad. Sci. USA 2002, 99:4520-4525.
33. Shryock JC, Snowdy S, Baraldi PG, Cacciari B, Spalluto G, Monopoli A, Ongini E, Baker SP, Belardinelli L A2A-adenosine receptor reserve for coronary vasodilation. Circulation 1998, 98:711-718.
34. Armstrong JM, Chen JF, Schwarzschild MA, Apasov S, Smith PT, Caldwell C, Chen P, Figler H, Sullivan G, Fink S, Linden J, Sitkovsky M Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes: studies of cells from A2A-receptor-gene-deficient mice. Biochem. J. 2001, 354:123-130.
35. By Y, Durand-Gorde JM, Condo J, Lejeune PJ, Mallet B, Carayon P, Guieu R, Ruf J Production of an agonist-like monoclonal antibody to the human A2A receptor of adenosine for clinical use. Mol. Immunol. 2009, 46:400-405.
36. Saadjian AY, Levy S, Franceschi F, Zouher I, Paganelli F, Guieu RP Role of endogenous adenosine as a modulator of syncope induced during tilt testing. Circulation 2002, 106:569-574.
37. Carrega L, Saadjian AY, Mercier L, Zouher I, Berge-Lefranc JL, Gerolami V, Giaime P, Sbragia P, Paganelli F, Fenouillet E, Levy S, Guieu RP Increased expression of adenosine A2A receptors in patients with spontaneous and head-up-tilt-induced syncope. Heart Rhythm. 2007, 4:870-876.
38. Deharo JC, Mechulan A, Giorgi R, Franceschi F, Prevot S, Peyrouse E, Condo J, By Y, Ruf J, Brignole M, Guieu R Adenosine plasma level and A2A adenosine receptor expression: correlation with laboratory tests in patients with neurally mediated syncope. Heart 2012, 98:855-859.
39. Guieu R, Sampieri F, Bechis G, Halimi G, Dussol B, Berland Y, Sampol J, Rochat H Development of an HPLC diode array detector method for the determination of human plasma adenosine concentrations. J. Liq. Chromatogr. Related Technol. 1999, 22:1829-1841.
40. Varani K, Laghi-Pasini F, Camurri A, Capecchi PL, Maccherini M, Diciolla F, Ceccatelli L, Lazzerini PE, Ulouglu C, Cattabeni F, Borea PA, Abbracchio MP Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation. FASEB J. 2003, 17:280-282.
41. Bali L, Cuisset T, Giorgi R, Monserrat C, Quilici J, Carrega L, Mouret JP, Nait-Saidi L, Mielot C, Lambert M, Guieu R, Bonnet JL Prognostic value of ischaemia-modified albumin in patients with non-ST-segment elevation acute coronary syndromes. Arch. Cardiovasc. Dis. 2008, 101:645-651.
42. By Y, Durand-Gorde JM, Condo J, Lejeune PJ, Fenouillet E, Guieu R, Ruf J Monoclonal antibody-assisted stimulation of adenosine A2A receptors induces simultaneous downregulation of CXCR4 and CCR5 on CD4+ T-cells. Hum. Immunol. 2010, 71:1073-1076.
43. Giaime P, Carrega L, Fenouillet E, Mercier L, Gerolami V, Ruf J, Sauze N, Brunet P, Saadjian A, Berland Y, Dussol B, Guieu R Relationship between A2A adenosine receptor expression and intradialytic hypotension during hemodialysis. J. Investig. Med. 2006, 54:473-477.
44. McNeil LK, Evavold BD TCR reserve: a novel principe of CD4 T cell activation by weak ligands. J. Immunol. 2003, 170:1224-1230.
45. Saadjian AY, Gerolami V, Giorgi R, Mercier L, Berge-Lefranc JL, Paganelli F, Ibrahim Z, By Y, Gueant JL, Levy S, Guieu RP Head-up tilt induced syncope and adenosine A2A receptor gene polymorphism. Eur. Heart J. 2009, 30:1510-1515.
46. Gurevich VV, Gurevich EV GPCR monomers and oligomers: it takes all kinds. Trends Neurosci. 2008, 31:74-81.
47. Allen MD, Neumann S, Gershengorn MC Occupancy of both sites on the thyrotropin (TSH) receptor dimer is necessary for phosphoinositide signaling. FASEB J. 2011, 25:3687-3694.